Clinical Trial Update: Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial is evaluating BLEX 404 in combination with docetaxel for advanced or metastatic triple-negative breast cancer; the study status is N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• BLEX 404
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: BioLite, Inc. | Conditions: Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING